Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
Ticker SymbolAORT
Company nameArtivion Inc
IPO dateFeb 12, 1993
CEOMr. James Patrick (Pat) Mackin
Number of employees1600
Security typeOrdinary Share
Fiscal year-endFeb 12
Address1655 Roberts Boulevard N W
CityKENNESAW
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code30144
Phone17704193355
Websitehttps://artivion.com/
Ticker SymbolAORT
IPO dateFeb 12, 1993
CEOMr. James Patrick (Pat) Mackin
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data